RWM
PBYI icon

Rialto Wealth Management’s Puma Biotechnology PBYI Stock Holding History

Rialto Wealth Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Hold
1,450
– – ﹤0.01% 509
2026
Q1 		$9.27K Hold
1,450
– – ﹤0.01% 476
2025
Q4 		$8.63K Hold
1,450
– – ﹤0.01% 461
2025
Q3 		$7.7K Hold
1,450
– – ﹤0.01% 449
2025
Q2 		$4.97K Hold
1,450
– – ﹤0.01% 470
2025
Q1 		$4.29K Buy
+1,450
New +$4.54K ﹤0.01% 464

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rialto Wealth Management's PBYI Position: Q2 2026 in Review

Rialto Wealth Management held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 1,450 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Rialto Wealth Management first reported a position in PBYI in Q1 2025 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Rialto Wealth Management held 1,450 shares of Puma Biotechnology worth $11.8K as of Q2 2026.
  • Rialto Wealth Management left its Puma Biotechnology share count unchanged in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #509 holding.
  • Rialto Wealth Management first reported a position in Puma Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.